Cargando…

An aetiology‐based subanalysis of the Telerehabilitation in Heart Failure Patients (TELEREH‐HF) trial

AIMS: The aim of our study was to analyse the benefits of a 9 week hybrid comprehensive telerehabilitation (HCTR) programme in heart failure (HF) patients according to aetiology, as a subanalysis of the Telerehabilitation in Heart Failure Patients (TELEREH‐HF) trial. METHODS AND RESULTS: Overall, 55...

Descripción completa

Detalles Bibliográficos
Autores principales: Szalewska, Dominika, Główczyńska, Renata, Piotrowicz, Ryszard, Kowalik, Ilona, Pencina, Michael J., Opolski, Grzegorz, Zaręba, Wojciech, Banach, Maciej, Orzechowski, Piotr, Pluta, Sławomir, Irzmański, Robert, Kalarus, Zbigniew, Piotrowicz, Ewa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006702/
https://www.ncbi.nlm.nih.gov/pubmed/33527740
http://dx.doi.org/10.1002/ehf2.13189
_version_ 1783672359725563904
author Szalewska, Dominika
Główczyńska, Renata
Piotrowicz, Ryszard
Kowalik, Ilona
Pencina, Michael J.
Opolski, Grzegorz
Zaręba, Wojciech
Banach, Maciej
Orzechowski, Piotr
Pluta, Sławomir
Irzmański, Robert
Kalarus, Zbigniew
Piotrowicz, Ewa
author_facet Szalewska, Dominika
Główczyńska, Renata
Piotrowicz, Ryszard
Kowalik, Ilona
Pencina, Michael J.
Opolski, Grzegorz
Zaręba, Wojciech
Banach, Maciej
Orzechowski, Piotr
Pluta, Sławomir
Irzmański, Robert
Kalarus, Zbigniew
Piotrowicz, Ewa
author_sort Szalewska, Dominika
collection PubMed
description AIMS: The aim of our study was to analyse the benefits of a 9 week hybrid comprehensive telerehabilitation (HCTR) programme in heart failure (HF) patients according to aetiology, as a subanalysis of the Telerehabilitation in Heart Failure Patients (TELEREH‐HF) trial. METHODS AND RESULTS: Overall, 555 (65.3%) patients with ischaemic (IS) and 295 (34.7%) patients with non‐ischaemic (NIS) HF aetiology were randomized. There were no differences between the effect of HCTR and usual care (UC) on the primary outcome of number of days alive and out of the hospital in 26 months from the time of randomization in either aetiology (Wilcoxon–Mann–Whitney test), and no heterogeneity of effect between the aetiologies was noted (van Elteren test, P = 0.746). In Cox proportional hazards regression analysis, treatment was not independently associated with the secondary outcomes. For all‐cause mortality, the adjusted hazard ratio for HCTR vs. UC was 0.90 (95% confidence interval, 0.54–1.51) in IS and 1.42 (95% confidence interval, 0.69–2.94) in NIS (P interaction = 0.316). Differences between HCTR and UC in terms of change in the 6 min walk test distance and cardiopulmonary exercise test time after 9 weeks reached statistical significance in the IS arm (P = 0.015 and P < 0.001, respectively), but not in the NIS arm; however, tests of heterogeneity indicated no statistically significant differences. CONCLUSIONS: The trial showed no difference between HCTR and UC in the primary outcome of percentage of days alive and out of the hospital for either IS or NIS aetiology. Moreover, the magnitude of changes in the clinical and functional statuses of the HF patients did not differ by aetiology. HCTR might have had beneficial effects on the 6 min walk test distance and cardiopulmonary exercise test time after 9 weeks in the IS patients; however, the effect was not statistically significantly different from that observed in the NIS patients.
format Online
Article
Text
id pubmed-8006702
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-80067022021-04-01 An aetiology‐based subanalysis of the Telerehabilitation in Heart Failure Patients (TELEREH‐HF) trial Szalewska, Dominika Główczyńska, Renata Piotrowicz, Ryszard Kowalik, Ilona Pencina, Michael J. Opolski, Grzegorz Zaręba, Wojciech Banach, Maciej Orzechowski, Piotr Pluta, Sławomir Irzmański, Robert Kalarus, Zbigniew Piotrowicz, Ewa ESC Heart Fail Original Research Articles AIMS: The aim of our study was to analyse the benefits of a 9 week hybrid comprehensive telerehabilitation (HCTR) programme in heart failure (HF) patients according to aetiology, as a subanalysis of the Telerehabilitation in Heart Failure Patients (TELEREH‐HF) trial. METHODS AND RESULTS: Overall, 555 (65.3%) patients with ischaemic (IS) and 295 (34.7%) patients with non‐ischaemic (NIS) HF aetiology were randomized. There were no differences between the effect of HCTR and usual care (UC) on the primary outcome of number of days alive and out of the hospital in 26 months from the time of randomization in either aetiology (Wilcoxon–Mann–Whitney test), and no heterogeneity of effect between the aetiologies was noted (van Elteren test, P = 0.746). In Cox proportional hazards regression analysis, treatment was not independently associated with the secondary outcomes. For all‐cause mortality, the adjusted hazard ratio for HCTR vs. UC was 0.90 (95% confidence interval, 0.54–1.51) in IS and 1.42 (95% confidence interval, 0.69–2.94) in NIS (P interaction = 0.316). Differences between HCTR and UC in terms of change in the 6 min walk test distance and cardiopulmonary exercise test time after 9 weeks reached statistical significance in the IS arm (P = 0.015 and P < 0.001, respectively), but not in the NIS arm; however, tests of heterogeneity indicated no statistically significant differences. CONCLUSIONS: The trial showed no difference between HCTR and UC in the primary outcome of percentage of days alive and out of the hospital for either IS or NIS aetiology. Moreover, the magnitude of changes in the clinical and functional statuses of the HF patients did not differ by aetiology. HCTR might have had beneficial effects on the 6 min walk test distance and cardiopulmonary exercise test time after 9 weeks in the IS patients; however, the effect was not statistically significantly different from that observed in the NIS patients. John Wiley and Sons Inc. 2021-02-01 /pmc/articles/PMC8006702/ /pubmed/33527740 http://dx.doi.org/10.1002/ehf2.13189 Text en © 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research Articles
Szalewska, Dominika
Główczyńska, Renata
Piotrowicz, Ryszard
Kowalik, Ilona
Pencina, Michael J.
Opolski, Grzegorz
Zaręba, Wojciech
Banach, Maciej
Orzechowski, Piotr
Pluta, Sławomir
Irzmański, Robert
Kalarus, Zbigniew
Piotrowicz, Ewa
An aetiology‐based subanalysis of the Telerehabilitation in Heart Failure Patients (TELEREH‐HF) trial
title An aetiology‐based subanalysis of the Telerehabilitation in Heart Failure Patients (TELEREH‐HF) trial
title_full An aetiology‐based subanalysis of the Telerehabilitation in Heart Failure Patients (TELEREH‐HF) trial
title_fullStr An aetiology‐based subanalysis of the Telerehabilitation in Heart Failure Patients (TELEREH‐HF) trial
title_full_unstemmed An aetiology‐based subanalysis of the Telerehabilitation in Heart Failure Patients (TELEREH‐HF) trial
title_short An aetiology‐based subanalysis of the Telerehabilitation in Heart Failure Patients (TELEREH‐HF) trial
title_sort aetiology‐based subanalysis of the telerehabilitation in heart failure patients (telereh‐hf) trial
topic Original Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006702/
https://www.ncbi.nlm.nih.gov/pubmed/33527740
http://dx.doi.org/10.1002/ehf2.13189
work_keys_str_mv AT szalewskadominika anaetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial
AT głowczynskarenata anaetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial
AT piotrowiczryszard anaetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial
AT kowalikilona anaetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial
AT pencinamichaelj anaetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial
AT opolskigrzegorz anaetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial
AT zarebawojciech anaetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial
AT banachmaciej anaetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial
AT orzechowskipiotr anaetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial
AT plutasławomir anaetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial
AT irzmanskirobert anaetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial
AT kalaruszbigniew anaetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial
AT piotrowiczewa anaetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial
AT szalewskadominika aetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial
AT głowczynskarenata aetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial
AT piotrowiczryszard aetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial
AT kowalikilona aetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial
AT pencinamichaelj aetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial
AT opolskigrzegorz aetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial
AT zarebawojciech aetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial
AT banachmaciej aetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial
AT orzechowskipiotr aetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial
AT plutasławomir aetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial
AT irzmanskirobert aetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial
AT kalaruszbigniew aetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial
AT piotrowiczewa aetiologybasedsubanalysisofthetelerehabilitationinheartfailurepatientstelerehhftrial